Recent findings on chimeric antigen receptor (CAR)-engineered immune cell therapy in solid tumors and hematological malignancies

Recent findings on chimeric antigen receptor (CAR)-engineered immune cell therapy in solid tumors and hematological malignancies

Abstract Advancements in adoptive cell therapy over the last four decades have revealed various new therapeutic strategies, such as chimeric antigen receptors (CARs), which are dedicated immune cells that are engineered and administered to eliminate cancer cells. In this context, CAR T-cells have sh...

Full description

Bibliographic Details
Main Authors: Ali Keshavarz, Ali Salehi, Setareh Khosravi, Yasaman Shariati, Navid Nasrabadi, Mohammad Saeed Kahrizi, Sairan Maghsoodi, Amirhossein Mardi, Ramyar Azizi, Samira Jamali, Farnoush Fotovat
Format: Article
Language:English
Published: BMC 2022-09-01
Series:Stem Cell Research & Therapy
Subjects:
Immunotherapy
Chimeric antigen receptors
CAR T-cell
CAR-NK cell
CAR-M solid tumors
Hematological malignancies
Online Access:https://doi.org/10.1186/s13287-022-03163-w

Internet

https://doi.org/10.1186/s13287-022-03163-w

Similar Items